Holen Sie sich die Stockscreener-App
59.19
0.27%
-0.16
Schlusskurs vom Vortag:
$59.35
Offen:
$59.61
24-Stunden-Volumen:
1.77M
Relative Volume:
0.70
Marktkapitalisierung:
$11.13B
Einnahmen:
$516.85M
Nettoeinkommen (Verlust:
$174.11M
KGV:
68.03
EPS:
0.87
Netto-Cashflow:
$217.38M
1W Leistung:
-0.24%
1M Leistung:
+6.46%
6M Leistung:
+1.61%
1J Leistung:
+149.12%
1-Tages-Spanne:
$58.75
$60.83
1-Wochen-Bereich:
$56.76
$60.83
52-Wochen-Spanne:
$22.96
$85.21
Doximity Inc Stock (DOCS) Company Profile
Firmenname
Doximity Inc
Sektor
Branche
Telefon
(650) 549-4330
Adresse
500 THIRD STREET, SAN FRANCISCO
Vergleichen Sie DOCS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DOCS
Doximity Inc
|
59.19 | 11.13B | 516.85M | 174.11M | 217.38M | 0.87 |
|
VEEV
Veeva Systems Inc
|
237.05 | 38.54B | 2.75B | 714.14M | 1.09B | 4.33 |
|
TEM
Tempus Ai Inc
|
61.37 | 9.87B | 640.44M | -743.28M | -206.93M | -11.29 |
|
HQY
Healthequity Inc
|
90.40 | 7.83B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
40.01 | 7.04B | 906.14M | -52.62M | 89.62M | -0.3621 |
Doximity Inc Stock (DOCS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-07 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2025-02-07 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2024-12-20 | Eingeleitet | Stephens | Equal-Weight |
| 2024-12-04 | Eingeleitet | Mizuho | Neutral |
| 2024-11-15 | Eingeleitet | Goldman | Neutral |
| 2024-11-14 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2024-11-13 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2024-11-08 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-11-08 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2024-10-15 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2024-08-09 | Hochstufung | Needham | Hold → Buy |
| 2024-07-18 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2024-04-25 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2024-02-26 | Eingeleitet | Leerink Partners | Market Perform |
| 2024-01-03 | Eingeleitet | Barclays | Equal Weight |
| 2024-01-02 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2023-08-09 | Herabstufung | Guggenheim | Buy → Neutral |
| 2023-08-09 | Herabstufung | Needham | Buy → Hold |
| 2023-08-03 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2023-05-01 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2023-01-06 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2022-10-31 | Eingeleitet | Wells Fargo | Overweight |
| 2022-10-24 | Eingeleitet | Evercore ISI | In-line |
| 2022-10-13 | Eingeleitet | BTIG Research | Neutral |
| 2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2022-09-07 | Eingeleitet | Truist | Hold |
| 2022-08-05 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2022-07-28 | Eingeleitet | Berenberg | Buy |
| 2022-05-18 | Bestätigt | BofA Securities | Neutral |
| 2022-05-18 | Bestätigt | Goldman | Buy |
| 2022-05-18 | Bestätigt | Guggenheim | Buy |
| 2022-05-18 | Bestätigt | Jefferies | Buy |
| 2022-05-18 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2022-05-18 | Bestätigt | Needham | Buy |
| 2022-04-07 | Eingeleitet | Guggenheim | Buy |
| 2022-04-04 | Eingeleitet | BofA Securities | Neutral |
| 2022-02-11 | Eingeleitet | Goldman | Buy |
| 2021-12-14 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2021-12-02 | Eingeleitet | Jefferies | Buy |
| 2021-11-17 | Eingeleitet | Robert W. Baird | Outperform |
| 2021-11-10 | Bestätigt | Canaccord Genuity | Buy |
| 2021-11-10 | Bestätigt | Goldman | Neutral |
| 2021-11-10 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2021-11-10 | Bestätigt | Needham | Buy |
| 2021-11-10 | Bestätigt | Piper Sandler | Overweight |
| 2021-08-26 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2021-07-19 | Eingeleitet | Canaccord Genuity | Buy |
| 2021-07-19 | Eingeleitet | Goldman | Neutral |
| 2021-07-19 | Eingeleitet | JP Morgan | Overweight |
| 2021-07-19 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2021-07-19 | Eingeleitet | Piper Sandler | Overweight |
| 2021-07-19 | Eingeleitet | Raymond James | Outperform |
| 2021-07-19 | Eingeleitet | SVB Leerink | Outperform |
| 2021-07-19 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Doximity Inc Aktie (DOCS) Neueste Nachrichten
Hsbc Holdings PLC Makes New $891,000 Investment in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
AQR Capital Management LLC Grows Position in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Doximity, Inc. (NASDAQ:DOCS) Shares Sold by Durable Capital Partners LP - MarketBeat
33,831 Shares in Doximity, Inc. (NASDAQ:DOCS) Acquired by Brevan Howard Capital Management LP - MarketBeat
Price T Rowe Associates Inc. MD Cuts Position in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Northern Trust Corp Grows Position in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Doximity, Inc. (NASDAQ:DOCS) Shares Sold by ArrowMark Colorado Holdings LLC - MarketBeat
Comerica Bank Has $4.93 Million Stock Position in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Bayesian Capital Management LP Acquires Shares of 40,300 Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
3 Reasons We Love Doximity (DOCS) - The Globe and Mail
Axa S.A. Buys 262,004 Shares of Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Algert Global LLC Raises Position in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
HSBC Holdings PLC Acquires 16,569 Shares of Doximity, Inc. (NASDAQ:DOCS) - paginasiete.bo
Doximity, Inc. (NASDAQ:DOCS) Shares Purchased by Integrated Wealth Concepts LLC - MarketBeat
Doximity (DOCS) Gains As Market Dips: What You Should Know - Yahoo Finance
Sweetgreen Rises 22% on Raised Forecasts, Doximity Jumps 30%, Rocket Lab Soars 14% on 71% Revenue Growth, and More - ADVFN
Pinebridge Investments L.P. Decreases Stake in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Nebula Research & Development LLC Acquires Shares of 11,888 Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Aquatic Capital Management LLC Cuts Position in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Guggenheim Capital LLC Takes $359,000 Position in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Lord Abbett & CO. LLC Has $34.95 Million Stock Holdings in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
MetLife Investment Management LLC Grows Position in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Press Release Distribution & PR Platform - ACCESS Newswire
Marshall Wace LLP Takes Position in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Doximity: Strong Fundamentals And Pharma Tailwinds Meet An Overpriced Valuation - Seeking Alpha
Mariner LLC Grows Stake in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
How To Trade (DOCS) - news.stocktradersdaily.com
T. Rowe Price Investment Management Inc. Sells 505,185 Shares of Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Doximity: Strong Platform, Growth Proof Needed For Valuation Comfort - Seeking Alpha
Regulatory Breakthroughs and New Technologies Drive Healthcare’s AI Evolution - Baystreet.ca
Is Coya Therapeutics, Inc. (COYA) Outperforming Other Medical Stocks This Year? - Yahoo Finance
Doximity, Inc. (NASDAQ:DOCS) Holdings Raised by Oberweis Asset Management Inc. - MarketBeat
Canada Pension Plan Investment Board Buys 81,300 Shares of Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Massar Capital Management LP Buys New Shares in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Finanzdaten der Doximity Inc-Aktie (DOCS)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.90%
1.33%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):